# iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)

> **NCT03207334** · PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Midostaurin
- **DRUG:** Cytarabine

## Key facts

- **NCT ID:** NCT03207334
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-11
- **Primary completion:** 2021-01
- **Final completion:** 2022-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2018-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03207334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03207334, "iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03207334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*